Group One Trading’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Group One Trading’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1	Closed	-$150	–	8157
2023 Q2	$150	Hold	1	–	–	﹤0.01%	7490
2023 Q1	$156	Sell	1 -31	-97%	-$6.07K	﹤0.01%	7010
2022 Q4	$4.01K	Sell	32 -457	-93%	-$76.4K	﹤0.01%	6426
2022 Q3	$130K	Sell	489 -23	-4%	-$8.76K	﹤0.01%	4529
2022 Q2	$227K	Sell	512 -133	-21%	-$94K	﹤0.01%	4170
2022 Q1	$799K	Buy	645 +557	+633%	+$758K	﹤0.01%	3317
2021 Q4	$221K	Sell	88 -98	-53%	-$598K	﹤0.01%	4979
2021 Q3	$3.4M	Buy	186 +158	+564%	+$2.51M	﹤0.01%	2104
2021 Q2	$292K	Buy	28 +25	+833%	+$210K	﹤0.01%	4815
2021 Q1	$22K	Buy	+3	New	+$21.6K	﹤0.01%	6724

Other funds holding IRLA

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading's IRLA Position: Q1 2026 in Review

Group One Trading sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q1 2026, closing a stake of 702 shares — an estimated $141K sold.

Group One Trading first reported a position in IRLA in Q4 2020 and held it in 11 quarters. The position peaked at $647K in Q1 2022. 43 funds tracked by Wall St. Rank hold IRLA as of Q1 2026.

Group One Trading reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 702 IRulya Therapeutics Inc. Common Stock shares in Q1 2026, an estimated $141K.
Group One Trading first reported a position in IRulya Therapeutics Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Group One Trading's IRulya Therapeutics Inc. Common Stock position peaked at $647K in Q1 2022.
43 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.